Acadian Asset Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$40.5M Sell
2,533,492
-1,384,958
-35% -$22.1M 0.08% 201
2025
Q1
$76.1M Sell
3,918,450
-845,036
-18% -$16.4M 0.22% 103
2024
Q4
$105M Buy
4,763,486
+374,874
+9% +$8.26M 0.3% 73
2024
Q3
$73.9M Buy
4,388,612
+1,629,453
+59% +$27.4M 0.23% 117
2024
Q2
$33M Sell
2,759,159
-137,338
-5% -$1.64M 0.1% 179
2024
Q1
$32.1M Buy
2,896,497
+612,787
+27% +$6.78M 0.11% 161
2023
Q4
$19.7M Buy
2,283,710
+637,230
+39% +$5.51M 0.08% 213
2023
Q3
$12.6M Buy
1,646,480
+1,230,244
+296% +$9.39M 0.05% 253
2023
Q2
$2.99M Buy
416,236
+294,778
+243% +$2.11M 0.01% 590
2023
Q1
$733K Buy
+121,458
New +$733K ﹤0.01% 957
2022
Q1
Sell
-97,149
Closed -$773K 1655
2021
Q4
$773K Buy
+97,149
New +$773K ﹤0.01% 895